Universe Pharmaceuticals Meeting Adjourned Due to Lack of Quorum
Ticker: UPC · Form: 6-K · Filed: Aug 26, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: meeting-adjournment, corporate-governance, shareholder-meeting
TL;DR
Universe Pharma's shareholder meeting postponed to Sept 2 due to no quorum.
AI Summary
Universe Pharmaceuticals INC convened its 2025 annual general meeting on August 26, 2025, but it was adjourned due to a lack of quorum. The meeting has been rescheduled for September 2, 2025, at 10:00 a.m. Beijing Time, at the company's address in Ji'an, Jiangxi, China.
Why It Matters
The adjournment of the annual general meeting may indicate shareholder engagement issues or logistical challenges, potentially impacting corporate governance and decision-making processes.
Risk Assessment
Risk Level: low — The filing is a routine procedural update regarding a meeting adjournment, with no immediate financial or operational impact disclosed.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the report
- August 26, 2025 (date) — Date of the original annual general meeting
- September 2, 2025 (date) — Rescheduled date for the annual general meeting
- 2025 Annual General Meeting (event) — The meeting that was adjourned
FAQ
What was the specific reason for the lack of quorum at the 2025 Annual General Meeting?
The filing states that the meeting was adjourned 'due to a lack of quorum' but does not provide further specific details on why a quorum was not met.
When and where will the rescheduled 2025 Annual General Meeting take place?
The meeting is rescheduled for September 2, 2025, at 10:00 a.m., Beijing Time, at 265 Jingjiu Avenue, Ji'an, Jiangxi, China.
Is Universe Pharmaceuticals INC required to file annual reports under Form 20-F?
Yes, the filing indicates with a checkmark that the registrant files annual reports under cover of Form 20-F.
What is the principal business address of Universe Pharmaceuticals INC?
The principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China, 343100.
What is the SIC code for Universe Pharmaceuticals INC?
The Standard Industrial Classification (SIC) code for Universe Pharmaceuticals INC is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 209 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2025-08-26 16:05:31
Filing Documents
- ea0254656-6k_universe.htm (6-K) — 9KB
- 0001213900-25-080750.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Universe Pharmaceuticals INC. Date: August 26, 2025 By: /s/ Gang Lai Gang Lai Chief Executive Officer 2